ReviewExpert opinion on investigational drugs2010

Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib.

Pearlie K Epling-Burnette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.